Sunil Rajasekar - 22 Apr 2026 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Reporting relationship: EVP Chief Prod & Strat Officer
Issuer ticker: HQY
Reported as of: 22 Apr 2026
Net transaction value: -$1,367
SEC form: 4
Accepted by SEC: 19 Oct 2026, 17:30:59 UTC
Prior SEC filing: 12 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Newton, Attorney-in-Fact

Filing notes and source

Key filing fact

Sunil Rajasekar filed Form 4 for HEALTHEQUITY, INC. (HQY) on 19 Oct 2026.

Key facts

This page summarizes Sunil Rajasekar's Form 4 filing for HEALTHEQUITY, INC. (HQY).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 19 Oct 2026, 17:30.

Change

Previous filing in this sequence was filed on 12 May 2026.
Current net transaction value: -$1,367.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001934884 Primary reporting owner

Rajasekar Sunil

Relationship: EVP Chief Prod & Strat Officer
Address: C/O HEALTHEQUITY, INC., 15 W. SCENIC POINTE DR., STE. 100, DRAPER
Signature: /s/ Michael Newton, Attorney-in-Fact
Signature date: 19 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HQY transaction

Common Stock

Sale

Transaction value: $1,905
Shares: -23
Change %: -0.04%
Price: $82.81
Shares after: 53,382
Date: 22 Apr 2026
Ownership: Direct
Footnotes: F1, F2, F3

HQY transaction

Common Stock

Purchase

Transaction value: $2,186
Shares: +23
Change %: +0.04%
Price: $95.06
Shares after: 53,405
Date: 08 Jul 2026
Ownership: Direct
Footnotes: F2, F3, F4

HQY transaction

Common Stock

Sale

Transaction value: $11,405
Shares: -108
Change %: -0.2%
Price: $105.60
Shares after: 53,297
Date: 24 Aug 2026
Ownership: Direct
Footnotes: F1, F2, F3

HQY transaction

Common Stock

Purchase

Transaction value: $9,756
Shares: +108
Change %: +0.2%
Price: $90.33
Shares after: 53,405
Date: 15 Oct 2026
Ownership: Direct
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents shares sold in a short sale.

Footnote F2

The transactions reported were executed in broker-managed discretionary accounts without the reporting person's knowledge. The reporting of these transactions was untimely because the reporting person did not become aware of the transactions at the time they occurred.

Footnote F3

The reporting person has voluntarily paid to the issuer a de minimis amount (approximately $1,650), which represent all "profits" pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, that resulted from the transactions reported herein.

Footnote F4

Represents shares delivered to cover the previous short sale.

SEC remarks

The Power of Attorney given by Mr. Rajasekar was previously filed with the U.S. Securities and Exchange Commission on May 12, 2026 as an exhibit to a statement on Form 3 filed by Mr. Rajasekar with respect to HealthEquity, Inc. and is hereby incorporated by reference.